Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dexmethylphenidate
2. Focalin
3. Focalin Xr
4. Hydrochloride, Dexmethylphenidate
5. Xr, Focalin
1. Dexmethylphenidate Hcl
2. Focalin
3. D-threo-methylphenidate Hydrochloride
4. 19262-68-1
5. Focalin Xr
6. 23655-65-4
7. Metadate Cd
8. Metadate Er
9. Equasym Xl
10. Dexmethylphenidate Hydrochloride [usan]
11. Ritalin
12. 4b3sc438hi
13. Dex-methylphenidate Hydrochloride
14. Methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;hydrochloride
15. 1678ok0e08
16. Methylphenidate D-threo-form Hydrochloride
17. Methyl (2r)-phenyl((2r)-piperidin-2-yl)acetate Hydrochloride
18. 19262-68-1 (hcl)
19. Methyl (2r)-2-phenyl-2-[(2r)-piperidin-1-ium-2-yl]acetate;chloride
20. Quillichew
21. Quillivant
22. Aptensio
23. Foquest
24. Oros Mph
25. Aptensio Xr
26. Methylin Er
27. Ritalin La
28. Ritalin Sr
29. Chembl904
30. (r)-methyl 2-phenyl-2-((r)-piperidin-2-yl)acetate Hydrochloride
31. Daytrana
32. Dexmethylphenidate Hydrochloride (usan)
33. Spd544
34. Spd-544
35. Dl-threo-methylphenidate Hcl
36. Biphentin
37. Equasym
38. Methypatch
39. Metadate Mr
40. Unii-1678ok0e08
41. Equasym Ir
42. Ritalin Qd
43. Focalin (tn)
44. Dl-threo-methylphenidate Hydrochloride
45. Adhansia Xr
46. Jornay Pm
47. Methyl .alpha.-phenyl-2-piperidineacetate Hydrochloride
48. Unii-4b3sc438hi
49. Nwp-06
50. Dtxsid50940927
51. D-threo Methylphenidate Hydrochloride
52. Akos027321667
53. Rac-threo-methylphenidate Hydrochloride
54. 2-piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (alphar,2r)-
55. 2-piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (r*,r*)- (+-)-
56. 2-piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (r-(r*,r*))-
57. Methylphenidate Hydrochloride [mi]
58. (+/-)-threo-methylphenidate Hydrochloride
59. Methylphenidate Hydrochloride [jan]
60. Methylphenidate Hydrochloride [mart.]
61. Methylphenidate Hydrochloride [vandf]
62. Methylphenidate Hydrochloride [who-dd]
63. D03721
64. Dexmethylphenidate Hydrochloride [mart.]
65. Dexmethylphenidate Hydrochloride [vandf]
66. Dexmethylphenidate Hydrochloride [who-dd]
67. Methylphenidate Hydrochloride [orange Book]
68. Methylphenidate Hydrochloride Cii [usp-rs]
69. Methylphenidate Hydrochloride [ep Monograph]
70. Methylphenidate Hydrochloride [usp Monograph]
71. Dexmethylphenidate Hydrochloride [orange Book]
72. Methylphenidate D-threo-form Hydrochloride [mi]
73. Q47487562
74. Azstarys Component Dexmethylphenidate Hydrochloride
75. Dexmethylphenidate Hydrochloride Component Of Azstarys
76. Methyl Phenyl(piperidin-2-yl)acetate--hydrogen Chloride (1/1)
77. Methylphenidate Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
78. 2-piperidineacetic Acid, .alpha.-phenyl-, Methyl Ester, Hydrochloride, (r*,r*)-(+/-)-
79. 2-piperidineacetic Acid, .alpha.-phenyl-, Methyl Ester, Hydrochloride,(.alpha.r,2r)-
Molecular Weight | 269.77 g/mol |
---|---|
Molecular Formula | C14H20ClNO2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 269.1182566 g/mol |
Monoisotopic Mass | 269.1182566 g/mol |
Topological Polar Surface Area | 38.3 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 249 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Dexmethylphenidate hydrochloride |
Drug Label | Focalin (dexmethylphenidate hydrochloride) is the d-threo-enantiomer of racemic methylphenidate hydrochloride, which is a 50/50 mixture of the d-threo and l-threo-enantiomers. Focalin is a central nervous system (CNS) stimulant, available in 3 tabl... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 2.5mg; 5mg; 25mg; 30mg; 10mg; 15mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Watson Labs; Mylan Pharms; Teva Pharms; Intellipharmaceutics; Teva Pharms Usa |
2 of 6 | |
---|---|
Drug Name | Focalin |
PubMed Health | Dexmethylphenidate (By mouth) |
Drug Classes | CNS Stimulant |
Drug Label | Focalin (dexmethylphenidate hydrochloride) is the d-threo-enantiomer of racemic methylphenidate hydrochloride, which is a 50/50 mixture of the d-threo and l-threo-enantiomers. Focalin is a central nervous system (CNS) stimulant, available in 3 tabl... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Novartis |
3 of 6 | |
---|---|
Drug Name | Focalin xr |
PubMed Health | Dexmethylphenidate (By mouth) |
Drug Classes | CNS Stimulant |
Drug Label | Focalin XR is an extended-release formulation of dexmethylphenidate with a bi-modal release profile. Focalin XR uses the proprietary SODAS (Spheroidal Oral Drug Absorption System) technology. Each bead-filled Focalin XR capsule contains half the dose... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 25mg; 30mg; 15mg; 5mg; 10mg; 40mg; 20mg; 35mg |
Market Status | Prescription |
Company | Novartis |
4 of 6 | |
---|---|
Drug Name | Dexmethylphenidate hydrochloride |
Drug Label | Focalin (dexmethylphenidate hydrochloride) is the d-threo-enantiomer of racemic methylphenidate hydrochloride, which is a 50/50 mixture of the d-threo and l-threo-enantiomers. Focalin is a central nervous system (CNS) stimulant, available in 3 tabl... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 2.5mg; 5mg; 25mg; 30mg; 10mg; 15mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Watson Labs; Mylan Pharms; Teva Pharms; Intellipharmaceutics; Teva Pharms Usa |
5 of 6 | |
---|---|
Drug Name | Focalin |
PubMed Health | Dexmethylphenidate (By mouth) |
Drug Classes | CNS Stimulant |
Drug Label | Focalin (dexmethylphenidate hydrochloride) is the d-threo-enantiomer of racemic methylphenidate hydrochloride, which is a 50/50 mixture of the d-threo and l-threo-enantiomers. Focalin is a central nervous system (CNS) stimulant, available in 3 tabl... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Novartis |
6 of 6 | |
---|---|
Drug Name | Focalin xr |
PubMed Health | Dexmethylphenidate (By mouth) |
Drug Classes | CNS Stimulant |
Drug Label | Focalin XR is an extended-release formulation of dexmethylphenidate with a bi-modal release profile. Focalin XR uses the proprietary SODAS (Spheroidal Oral Drug Absorption System) technology. Each bead-filled Focalin XR capsule contains half the dose... |
Active Ingredient | Dexmethylphenidate hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 25mg; 30mg; 15mg; 5mg; 10mg; 40mg; 20mg; 35mg |
Market Status | Prescription |
Company | Novartis |
Dopamine Uptake Inhibitors
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15059
Submission : 2000-09-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-10
Pay. Date : 2018-06-28
DMF Number : 32902
Submission : 2018-06-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-11-07
Pay. Date : 2017-10-10
DMF Number : 29784
Submission : 2015-10-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-31
Pay. Date : 2013-07-23
DMF Number : 22998
Submission : 2009-09-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-24
Pay. Date : 2013-06-14
DMF Number : 20385
Submission : 2007-03-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17117
Submission : 2004-01-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-22
Pay. Date : 2018-04-06
DMF Number : 30657
Submission : 2016-10-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-02
Pay. Date : 2014-09-26
DMF Number : 13228
Submission : 1998-09-21
Status : Active
Type : II
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Dexmethylphenidate Hydrochloride
About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...
About the Company : Back in the year 1973, a team of individuals came up with such an idea – The idea called Alkem. Looking back at our 5 decades, illustrious journey, that one small idea has Not on...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
Dexmethylphenidate Hydrochloride
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
Dexmethylphenidate Hydrochloride
About the Company : Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of ...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Dexmethylphenidate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexmethylphenidate, including repackagers and relabelers. The FDA regulates Dexmethylphenidate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexmethylphenidate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexmethylphenidate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexmethylphenidate supplier is an individual or a company that provides Dexmethylphenidate active pharmaceutical ingredient (API) or Dexmethylphenidate finished formulations upon request. The Dexmethylphenidate suppliers may include Dexmethylphenidate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexmethylphenidate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexmethylphenidate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexmethylphenidate active pharmaceutical ingredient (API) in detail. Different forms of Dexmethylphenidate DMFs exist exist since differing nations have different regulations, such as Dexmethylphenidate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexmethylphenidate DMF submitted to regulatory agencies in the US is known as a USDMF. Dexmethylphenidate USDMF includes data on Dexmethylphenidate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexmethylphenidate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexmethylphenidate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexmethylphenidate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexmethylphenidate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexmethylphenidate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexmethylphenidate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexmethylphenidate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexmethylphenidate suppliers with NDC on PharmaCompass.
Dexmethylphenidate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexmethylphenidate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexmethylphenidate GMP manufacturer or Dexmethylphenidate GMP API supplier for your needs.
A Dexmethylphenidate CoA (Certificate of Analysis) is a formal document that attests to Dexmethylphenidate's compliance with Dexmethylphenidate specifications and serves as a tool for batch-level quality control.
Dexmethylphenidate CoA mostly includes findings from lab analyses of a specific batch. For each Dexmethylphenidate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexmethylphenidate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexmethylphenidate EP), Dexmethylphenidate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexmethylphenidate USP).
LOOKING FOR A SUPPLIER?